A new pilot study evaluating vitamin D and K status in children with and without low-energy fractures has published in Nutrients, an international, peer-reviewed journal for studies related to Human Nutrition.
The publication of this study Decreased Levels of Circulating Carboxylated Osteocalcin in Children with Low Energy Fractures: A Pilot Study is significant because it adds to the growing body of evidence that Vitamin K2 is a beneficial nutrient for both children and adults, comments Dr. Hogne Vik, chief medical officer at international vitamin K product and research specialist NattoPharma.
“This trial reaffirms the real health benefits improving K2 status delivers,” says Vik. “More importantly, it shines a light on the true impact improving K2 status has on children, our most precious resource.”
According to Dr. Vladimir Badmaev, author of the paper and principal and founder of American Medical Holdings, Inc: “The epidemiological evidence indicates a disturbing growth in the number of cases of low-energy fractures in healthy children and adolescents. There are multiple risk factors that may contribute to this growing health concern, and among the leading consideration are deficient or insufficient nutrition and nutrients, including calcium, vitamin D and vitamin K.”
Dr. Badmaev explains that the particular role of vitamin K2, especially menaquinone-7 (MK-7), has been highlighted in the literature and distinguished from vitamin K1 in maintaining calcium homeostasis and healthy skeletal system. “The epidemiological and clinical research provides a new nutritional paradigm for efficient, safe delivery of calcium that requires co-supplementation with both vitamins D and K.”
The study, which was was presented at The World Congress on Osteoprosis, Osteoarthritis, and Musculoskeletal Diseases, haas been published by leading European journal Nutrients.